COMPASS Pathways(DE:5Y6)
€8.25-0.20 (-2.37%)
DE:5Y6
COMPASS Pathways stock forecast
€8.25
At close:-0.20 (-2.37%)
COMPASS Pathways (5Y6) Stock Forecast & Price Target
7 Followers
5Y6 Analyst Ratings
Strong Buy
7Buy1Hold0Sell
Based on 8 analysts giving stock ratings to COMPASS Pathways in the past 3 months
5Y6 Stock 12 Month Forecast
Average Price Target
€23.68▲(186.98% Upside)Based on 8 Wall Street analysts offering 12 month price targets for COMPASS Pathways in the last 3 months. The average price target is EUR 23.68 with a high forecast of EUR 57.92 and a low forecast of EUR 8.91. The average price target represents a 186.98% change from the last price of EUR 8.25.
Past 12 Months12 Month ForecastJan2026Oct2026
High€57.92
Average€23.68
Low€8.91
Highest Price TargetHighest€57.92Average Price Target€23.68Lowest Price TargetLowest€8.91
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Patrick Trucchio | H.C. Wainwright | €57.92 | buy | 602.03%Upside | Reiterated | 11/09/26 | ||
| Leonid Timashev | RBC Capital | €18.71 | buy | 126.81%Upside | Reiterated | 11/09/26 | ||
| Thomas Shrader | BTIG | €22.28 | buy | 170.01%Upside | Reiterated | 11/09/26 | ||
| Sumant Kulkarni | Canaccord Genuity | €17.82 | buy | 116.01%Upside | Reiterated | 11/09/26 | ||
| Michael Okunewitch | Maxim Group | ― | buy | ― | Reiterated | 11/05/26 | ||
| Benjamin Burnett | Wells Fargo | €11.58→€8.91 | hold | 8.00%Upside | Reiterated | 11/04/26 | ||
| Paul Matteis | Stifel Nicolaus | €18.71 | buy | 126.81%Upside | Reiterated | 11/04/26 | ||
| Francois Brisebois | LifeSci Capital | €21.38 | buy | 159.21%Upside | Reiterated | 09/09/26 | ||
| Gavin Clark-Gartner | Evercore ISI | €18.71 | buy | 126.81%Upside | Reiterated | 08/10/26 | ||
| Judah Frommer | Morgan Stanley | €15.15→€16.04 | buy | 94.41%Upside | Reiterated | 08/06/26 | ||
| Madison Elsaadi | B. Riley Securities | €15.15→€19.60 | buy | 137.61%Upside | Reiterated | 08/06/26 | ||
| Ritu Baral | TD Cowen | €25.84 | buy | 213.21%Upside | Reiterated | 08/05/26 | ||
| Jay Olson | Oppenheimer | €17.82 | buy | 116.01%Upside | Reiterated | 07/07/26 | ||
| Rudy Li | Wolfe Research | €16.04 | buy | 94.41%Upside | Reiterated | 07/07/26 | ||
| Andrew Tsai | Jefferies | €16.04 | buy | 94.41%Upside | Reiterated | 05/14/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Patrick TrucchioH.C. Wainwright | BuyReiterated€57.92 | 11/09/26 | 602.03%Upside | ||
| Leonid TimashevRBC Capital | BuyReiterated€18.71 | 11/09/26 | 126.81%Upside | ||
| Thomas ShraderBTIG | BuyReiterated€22.28 | 11/09/26 | 170.01%Upside | ||
| Sumant KulkarniCanaccord Genuity | BuyReiterated€17.82 | 11/09/26 | 116.01%Upside | ||
| Michael OkunewitchMaxim Group | BuyReiterated | 11/05/26 | ― | ||
| Benjamin BurnettWells Fargo | HoldReiterated€11.58→€8.91 | 11/04/26 | 8.00%Upside | ||
| Paul MatteisStifel Nicolaus | BuyReiterated€18.71 | 11/04/26 | 126.81%Upside | ||
| Francois BriseboisLifeSci Capital | BuyReiterated€21.38 | 09/09/26 | 159.21%Upside | ||
| Gavin Clark-GartnerEvercore ISI | BuyReiterated€18.71 | 08/10/26 | 126.81%Upside | ||
| Judah FrommerMorgan Stanley | BuyReiterated€15.15→€16.04 | 08/06/26 | 94.41%Upside | ||
| Madison ElsaadiB. Riley Securities | BuyReiterated€15.15→€19.60 | 08/06/26 | 137.61%Upside | ||
| Ritu BaralTD Cowen | BuyReiterated€25.84 | 08/05/26 | 213.21%Upside | ||
| Jay OlsonOppenheimer | BuyReiterated€17.82 | 07/07/26 | 116.01%Upside | ||
| Rudy LiWolfe Research | BuyReiterated€16.04 | 07/07/26 | 94.41%Upside | ||
| Andrew TsaiJefferies | BuyReiterated€16.04 | 05/14/26 | 94.41%Upside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering COMPASS Pathways
3 Months
Success Rate9/13 ratings generated profit
69%
Average Return
+27.56%
Copying Michael Okunewitch's trades and holding each position for 3 Months would result in 69.23% of your transactions generating a profit, with an average return of +27.56% per trade.
1 Year
Success Rate9/13 ratings generated profit
69%
Average Return
+68.45%
Copying Michael Okunewitch's trades and holding each position for 1 Year would result in 69.23% of your transactions generating a profit, with an average return of +68.45% per trade.
2 Years
Success Rate11/13 ratings generated profit
85%
Average Return
+66.15%
Copying Michael Okunewitch's trades and holding each position for 2 Years would result in 84.62% of your transactions generating a profit, with an average return of +66.15% per trade.
5Y6 Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 22 | 20 | 20 | 10 | 10 |
| Buy | 5 | 7 | 7 | 4 | 2 |
| Hold | 1 | 3 | 3 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 28 | 30 | 30 | 16 | 13 |
In the current month, 5Y6 has received 12 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. 5Y6 average Analyst price target in the past 3 months is 23.68.
5Y6 Financial Forecast
High€-0.04
Consensus€-0.36
Low€-0.60
5Y6 Earnings Forecast
Next quarter’s earnings estimate for 5Y6 is -EUR 0.36 with a range of -EUR 0.60 to -EUR 0.04. The previous quarter’s EPS was -EUR 0.28. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
High€0.00
Consensus€0.00
Low€0.00
5Y6 Sales Forecast
Next quarter’s sales forecast for 5Y6 is EUR 0 with a range of EUR 0 to EUR 0. The previous quarter’s sales results were EUR 0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
5Y6 Stock Forecast FAQ
What is DE:5Y6’s average 12-month price target, according to analysts?
Based on analyst ratings, COMPASS Pathways’s 12-month average price target is €23.68.
What is DE:5Y6’s upside potential, based on the analysts’ average price target?
COMPASS Pathways has 186.98% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is COMPASS Pathways a Buy, Sell or Hold?
COMPASS Pathways has a consensus rating of Strong Buy, which is based on 7 buy ratings, 1 hold ratings and 0 sell ratings.
What is COMPASS Pathways’s share price target?
The average share price target for COMPASS Pathways is €23.68. This is based on 8 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €57.92, and the lowest forecast is €8.91. The average share price target represents a 186.98% increase from the current price of €8.25.
What do analysts say about COMPASS Pathways?
COMPASS Pathways’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Street analysts.
How can I buy shares of COMPASS Pathways?
To buy shares of DE:5Y6, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
